Supreme Court Denies Human Gene Patents
June 17, 2013
The Supreme Court rules against human gene patents in a severe blow to Myriad Genetics (NASDAQ: MYGN). Read More
from Energy and Capital
Rosetta (ROSG) Higher on Cancer Origin Test Data
June 13, 2013
Medicare Administrator Issues Final Local Coverage Determination for Rosetta Cancer Origin Test™
June 13, 2013
microRNA assay determined reasonable and necessary for providing an important niche in pathologic diagnoses of Cancer of Unknown Primary Read More
from PR Newswire
Bio-Wire Equity Surveillance – Closing Bell 6/7/2013
June 07, 2013
Thursday, June 6th, 2013 Overview Today was bullish for the broader market with the Dow moving+1.38% to 15,248, the S&P 500 moving +1.28% to 1643 and the NASDAQ moving+1.32% to 3469. Big pharma... Read More
from Bio-Wire.Com
Higher Open On Jobs Data
June 07, 2013
The markets opened sharply higher with the Dow leaping 159 points to 15,199 as the nation's employers added a greater than expected 175,000 jobs in May. Nasdaq climbed 27 points to 3451. Read More
category
Market News
StreetInsider.com Pre-Open Movers 6/7: (ROSG) (CCUR) (RALY) Higher; (TIVO) (IRM) (ZQK) Lower (more...)
June 07, 2013
Rosetta Genomics (ROSG) Adds PPO for Cancer Origin Test
June 07, 2013
Preferred Provider Organization network has more than 10 million covered lives; one-in-five Americans now covered for the Rosetta Cancer Origin Test™ Read More
from PR Newswire
Rosetta Genomics Announces Acceptance for Publication by Molecular Cancer of Rosetta Cancer Origin Test Manuscript
June 06, 2013
Fifth Validation Study Demonstrating Ability to Identify Tumor Origin in Patients with Cancer of Unknown or Uncertain Primary Shows 92% Accuracy, Highest Published Level to Date Read More
from PR Newswire
Bio-Wire Equity Surveillance – Closing Bell 6/3/2013
June 04, 2013
Tuesday, June 4rd, 2013 Overview We saw the broader market drop a little today in a virtual repeat of yesterday’s trading. Big pharma (Mkt Cap $10 B+) dropped -.61%, mid-sized pharma (Mkt Cap $2 B –... Read More
from Bio-Wire.Com
Stock to Watch: Rosetta Genomics Up 7.9% (ROSG)
June 04, 2013
Launches new corporate and product branding at ASCO 2013, reports strong attendance at Industry Expert Theater Presentation Read More
from PR Newswire
Monday, May 29th, 2013 Overview Big pharmaceutical companies moved up at an average of +1.2% today, while medium-sized pharmas/biotechs moved +1.3% (almost exactly the same). We saw twice the upward... Read More
from Bio-Wire.Com
Rosetta Genomics Announces Presence at ASCO 2013
May 28, 2013
Rosetta Genomics Announces Presence at ASCO 2013
May 28, 2013
Innovative microRNA based diagnostic test services to be showcased at Exhibit Booth 2101 and featured at an Industry Expert Theater Presentation Read More
from PR Newswire
from PR Newswire
Rosetta Genomics Announces Credentialing Agreement with Prime Health Services for miRview mets2
May 20, 2013
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here